GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Feedback PLC (LSE:FDBK) » Definitions » Net Current Asset Value

Feedback (LSE:FDBK) Net Current Asset Value : £0.38 (As of Nov. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Feedback Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Feedback's net current asset value per share for the quarter that ended in Nov. 2023 was £0.38.

The historical rank and industry rank for Feedback's Net Current Asset Value or its related term are showing as below:

LSE:FDBK' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.3   Med: 5.81   Max: 247.93
Current: 1.64

During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Feedback was 247.93. The lowest was 1.30. And the median was 5.81.

LSE:FDBK's Price-to-Net-Current-Asset-Value is ranked better than
86.75% of 249 companies
in the Healthcare Providers & Services industry
Industry Median: 6.25 vs LSE:FDBK: 1.64

Feedback Net Current Asset Value Historical Data

The historical data trend for Feedback's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Feedback Net Current Asset Value Chart

Feedback Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.17 0.48 0.78 0.54

Feedback Semi-Annual Data
May14 Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Nov22 May23 Nov23
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.78 0.66 0.54 0.38

Competitive Comparison of Feedback's Net Current Asset Value

For the Health Information Services subindustry, Feedback's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Feedback's Price-to-Net-Current-Asset-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Feedback's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Feedback's Price-to-Net-Current-Asset-Value falls into.



Feedback Net Current Asset Value Calculation

Feedback's Net Current Asset Value (NCAV) per share for the fiscal year that ended in May. 2023 is calculated as

Net Current Asset Value Per Share(A: May. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(7.998-0.855-0-0)/13.3347
=0.54

Feedback's Net Current Asset Value (NCAV) per share for the quarter that ended in Nov. 2023 is calculated as

Net Current Asset Value Per Share(Q: Nov. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(5.958-0.914-0-0)/13.335
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Feedback  (LSE:FDBK) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Feedback Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Feedback's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Feedback (LSE:FDBK) Business Description

Traded in Other Exchanges
Address
3-7 Temple Avenue, 201 Temple Chambers, London, GBR, EC4Y 0DT
Feedback PLC is a medical imaging software and tools company. It develops and markets imaging tools and software for clinical decision-making and also techniques and improved workflow for medical practitioners engaged in research and in treating patients. The company also entered into a joint venture for future clinical application of its products on patients with kidney stones and it has a medical imaging segment.

Feedback (LSE:FDBK) Headlines

No Headlines